Vanguard Group
IMGO

Vanguard Group’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Vanguard Group’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,265,741
Closed -$45.5M – 4653
2022
Q4 		$45.5M Buy
1,265,741
+29,469
+2% +$737K ﹤0.01% 2228
2022
Q3 		$18.6M Buy
1,236,272
+229,065
+23% +$3.72M ﹤0.01% 2660
2022
Q2 		$13.5M Buy
1,007,207
+214,106
+27% +$3.4M ﹤0.01% 2831
2022
Q1 		$15.3M Buy
793,101
+323,376
+69% +$6.71M ﹤0.01% 2925
2021
Q4 		$11.1M Sell
469,725
-265,656
-36% -$6.15M ﹤0.01% 3149
2021
Q3 		$14.7M Buy
+735,381
New +$15.8M ﹤0.01% 3027

Vanguard Group's IMGO Position: Q1 2023 in Review

Vanguard Group sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 1,265,741 shares — an estimated $45.5M sold.

Vanguard Group first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $45.5M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Vanguard Group reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Vanguard Group sold 1,265,741 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $45.5M.
  • Vanguard Group first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • Vanguard Group's Imago BioSciences, Inc. Common stock position peaked at $45.5M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.